MedTrace Logo

Prophylactic Effect of a CANDIDA Mouthwash, Containing the Curolox™ Peptide

NCT02308436 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-08-28

No results posted yet for this study

Summary

In vitro results showed a protective effect against acids for the mouthwash containing Curolox™ peptide. The goal of this in situ study is to detect the Curolox™ peptide under natural oral conditions on the tooth surface and to proof the in vitro results obtained. So far there are no effect and safety data of the Curolox™ mouthwash under natural oral conditions available.

Conditions

  • Erosion of Teeth, Unspecified

Interventions

DEVICE

Candida Mouthwash with Curolox™ Peptide

Prophylaxis - protection and care of teeth against caries \& acidic challenges

Sponsors & Collaborators

  • Mibelle AG

    lead INDUSTRY

Principal Investigators

  • Christian Besimo, Dr.med.dent. · Aeskulap Klinik

  • Ulrich P. Saxer, Dr.med.dent. · Aeskulap Klinik / PZZN

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02308436 on ClinicalTrials.gov